Latham & Watkins and Wilson Sonsini represented Affini-T Therapeutics, Inc. in the transaction. Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic...
You must be a Standard 1 Year member to access this content.
Latham & Watkins, Torys LLP and Goodwin represented Triumvira Immunologics in the transaction. Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Bionomics in the offering. Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the IPO. IO Biotech, Inc. has announced the pricing of its initial public offering of 7,150,000 shares of its common...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Pyxis Oncology, Inc., a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised Walgreens Boots Alliance on the deal, while Latham & Watkins represented VillageMD. Wilmer Cutler Pickering Hale and Dorr represented Kinnevik. Walgreens Boots Alliance signed...
You must be a Standard 1 Year member to access this content.
Herzog Fox & Neeman and Latham & Watkins advised Neogames on the deal. NeoGames S.A., a provider of online gaming technology and services to lottery operators,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Global-e Online on the deal, while Gornitzky represented the underwriters. Global-e Online Ltd. announced the pricing of its underwritten secondary offering by certain...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Goldfarb Seligman & Co. represented Itamar Medical in the transaction. Cooley and Gornitzky & Co. advised ZOLL Medical. Itamar™ Medical Ltd. (Nasdaq...
You must be a Standard 1 Year member to access this content.
Greenberg Traurig represented Memic, while Foley & Lardner represented MedTech. Latham & Watkins represented the placement agents. Memic Innovative Surgery Ltd., a medical device company dedicated...
You must be a Standard 1 Year member to access this content.
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Alpha Tau in the transaction, while Winston & Strawn represented the placement agent. Alpha Tau Medical Limited, the developer of the...
You must be a Standard 1 Year member to access this content.
